1h Free Analyst Time
The artificial intelligence in drug discovery market is forecasted to grow by USD 4.31 billion during 2024-2029, accelerating at a CAGR of 25.7% during the forecast period. The report on the artificial intelligence in drug discovery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of funding, government initiatives, and expansion of biotechnology sector.
The artificial intelligence in drug discovery market is segmented as below:
By Deployment
- Cloud-based
- On-premises
By Therapeutic Area
- Oncology
- Infectious diseases
- Neurology
- Metabolic diseases
- Others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the artificial intelligence in drug discovery market covers the following areas:
- Artificial Intelligence In Drug Discovery Market sizing
- Artificial Intelligence In Drug Discovery Market forecast
- Artificial Intelligence In Drug Discovery Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Deployment
9 Market Segmentation by Therapeutic Area
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global artificial intelligence in drug discovery market: Atomwise Inc., BenevolentAI, C4X Discovery Holdings PLC, Deep Genomics Inc., Enamine Ltd, Evotec SE, GNS Healthcare Inc., Insilico Medicine, PathAI Inc., Phenomic AI Inc., Recursion Pharmaceuticals, Roivant Sciences Ltd., Schrodinger Inc., Verge Analytics Inc., and Zoetis Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic partnerships."
According to the report, one of the major drivers for this market is the availability of funding.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Atomwise Inc.
- BenevolentAI
- C4X Discovery Holdings PLC
- Deep Genomics Inc.
- Enamine Ltd
- Evotec SE
- GNS Healthcare Inc.
- Insilico Medicine
- PathAI Inc.
- Phenomic AI Inc.
- Recursion Pharmaceuticals
- Roivant Sciences Ltd.
- Schrodinger Inc.
- Verge Analytics Inc.
- Zoetis Inc.
